Latest International Partnerships News

Tivan Limited has locked in $11.3 million in initial funding from ETFS Capital, marking a key step forward for the Speewah Fluorite Project in Western Australia. This strategic partnership accelerates development towards a Final Investment Decision expected in 2026.

Renascor Resources has completed major equipment installation and begun commissioning at its Australian Government co-funded Purified Spherical Graphite demonstration facility, marking a pivotal step in its sustainable battery anode materials strategy.

AKORA Resources has secured strong endorsement from Madagascar’s new government to upgrade its Bekisopa iron ore project licence from exploration to mining, paving the way for project advancement and investment.

Carnegie Clean Energy’s Spanish subsidiary has received a significant pre-financing payment from the European Commission to advance innovations in wave energy technology through the COIN Project.

Renascor Resources has hit key construction milestones at its Australian Government co-funded Purified Spherical Graphite (PSG) demonstration facility, maintaining schedule for on-site commissioning this quarter. The project aims to establish a competitive, HF-free PSG supply chain outside China.

Chrysos Corporation reported robust FY25 results driven by record sample volumes and expanded global deployments of its PhotonAssay technology. The company reiterates strong FY26 guidance amid growing international partnerships.

Green Critical Minerals has signed a landmark MoU with South Korea’s Komex Carbon Corporation to co-develop and commercialize Very High Density (VHD) carbon products, marking GCM’s first international commercial agreement and a key step toward revenue generation in 2026.

Merino & Co. initiates a new chapter with leadership changes and a strategic partnership to enter China’s premium apparel market, while investing heavily in growth during Q1 FY26.

Energy Transition Minerals Ltd has acquired the Penouta tin-tantalum-niobium mine in Spain at a significant discount, raised A$18 million in capital, and received a key arbitration ruling on its Greenland rare earths project.

Vectus Biosystems has signed a binding agreement to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics, while actively pursuing licensing opportunities for its lead drug VB0004 and others, particularly in China.

Echo IQ Limited has advanced its EchoSolv heart failure solution towards FDA submission, driven by a landmark clinical validation study and a sharp rise in US platform adoption. Strategic partnerships and international expansion efforts underscore the company’s growing footprint in cardiology AI.

BauMart Holdings reports progress in AI-driven international recruitment and sustainable building materials development, alongside a $180,000 capital raise to support growth initiatives.